Grammy-winning singer Michael Bolton, now 72, has opened up about his battle with glioblastoma - a rare and aggressive type ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

Background: Thioredoxin reductase (Trx) has been implicated in activation of hypoxia-inducible factor-1α, which is overexpressed in > 85% of renal cell carcinomas (RCCs). We evaluated the safety ...

Modifications of the intrinsic currents in neuronal circuits are more likely to result in loss of function than changes in synaptic strength.

24, 2025 — Prostate cancer has distinct genetic properties ... a key enzyme in lipid metabolism -- accelerates white blood cell aging and alters genes associated with the onset of blood ...

This enzyme helps glial cells—especially astrocytes—support neurons. For years, researchers have known that PHGDH levels rise in Alzheimer’s patients. Its protein and RNA appear in larger ...

Apr. 25, 2025 — Chimpanzee naive pluripotent stem cells (PSCs) can now be grown in cellular cultures, reveals a recent study. They successfully created chimpanzee early embryo models, called ...